Form 4: Accelerate Diagnostics Director Sells 200,000 Shares in Private Transaction

Director Jack W. Schuler sold 200,000 shares of Accelerate Diagnostics stock in a private transaction for tax planning purposes.

Summary

• Jack W. Schuler, a director at Accelerate Diagnostics, sold 200,000 shares of common stock on December 3, 2024.
• The shares were sold at a price of $1.57 per share.
• The transaction was a private sale to John Patience, a member of the issuer's board of directors.
• The sale was conducted for tax planning purposes.
• Following the transaction, Schuler directly owns 20,225 shares and indirectly owns 8,310,388 shares through the Jack W. Schuler Living Trust.
• Schuler also indirectly owns 5,497 shares through his spouse.

Sentiment

Score: 5

Explanation: The document is a neutral report of a stock sale by a director, with no indication of positive or negative sentiment.

Industry Context

This is a routine Form 4 filing, which is common when company insiders trade shares. It does not indicate any specific trend in the diagnostics industry.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies, and this transaction is not unusual.
• Private sales between board members are not uncommon for tax planning purposes.

Related Party Transactions

• The sale of 200,000 shares was to John Patience, a member of the issuer's board of directors.

Stakeholder Impact

• The transaction may have a minor impact on shareholders due to the change in ownership, but it is not expected to be significant.

Key Dates

Keywords

Accelerate Diagnostics, AXDX, insider trading, stock sale, director, Jack W. Schuler, private transaction, tax planning